The babies at greatest risk are those who were born very early or who were
diagnosed with chronic lung disease (also called bronchopulmonary dysplasia, or BPD), but even moderately premature babies can have respiratory problems as they grow.
The ability to counteract inflammation in the lungs by utilising the combined anti-inflammatory and reparative properties of MSCs could potentially reduce the inflammatory response in
individuals with chronic lung disease whilst also restoring lung function in these patients.
Although further research is needed to improve our understanding of how MSCs repair this damage, these findings suggest a promising role for MSC therapy in treating
patients with chronic lung disease.
This device could enable trials of NO to treat patients
with chronic lung diseases and certain kinds of heart failure and would make NO therapy available in parts of the world that don't have the resources that are currently required.»
Other areas of expertise include procedures to evaluate and treat disease in the airways, care of patients with cystic fibrosis, lung transplantation, respiratory therapy, rehabilitation of patients
with chronic lung disease, and breathing - related sleep disorders.
She is interested in the use of integrative medicine modalities such as Mindfulness Based Stress Reduction to improve quality of life for patients
with chronic lung disease and sleep disorders.